INDIAN WELLS, Calif., April 15, 2015 /PRNewswire/ -- According to the CDC, prostate cancer is among the most prevalent cancers in American men and is also the leading cause of death among men of all races. The CDC's 2011 statistics show that over 200,000 men were diagnosed with prostate cancer and 27,970 died from the disease. There is no prevention, but regular screening and better detection are crucial to decreasing the number of deaths every year.
These statistics are why it is important to note that, under the leadership of Dr. John F. Feller, owner and Medical Director of Desert Medical Imaging, the group has recently performed its 500th in-bore, MRI-guided prostate biopsy. "The technology targets prostate lesions in order to better grade and stage prostate cancer and reduce pain, bleeding and risk of infection," said Feller. "MRI-guided biopsies have proven to be more accurate than random, transrectal ultrasound (TRUS) biopsy, which has a documented false-negative rate of 30-35% for the detection of clinically significant prostate cancer."
Since its inception in 2009, the Desert Medical Imaging prostate program has served over 1,100 men and was involved in a five-year collaboration to develop the image-guidance system used for minimally invasive prostate intervention using MRI guidance.
About Desert Medical Imaging
Desert Medical Imaging is headquartered in Indian Wells, California. In September 1998, owner and medical director, Dr. John Feller, opened the first imaging center in Indian Wells and over the next ten years, opened additional centers in the Coachella Valley. All facilities provide magnetic resonance imaging (MRI), spiral computed tomography (CT) imaging and ultrasound services. The Indian Wells facility is affiliated with Indian Wells PET/CT Center and is the location of a CME accredited course on prostate MRI and MR-guided intervention. For more information on Desert Medical Imaging visit desertmedicalimaging.com or call 760-766-2047.
SOURCE Desert Medical Imaging